Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders (Q34735243)

4 August 2017

1 reference

title

Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders (English)

1 reference

4 August 2017

1 reference

Jonathan Kipnis

1 reference

4 August 2017

Michal Schwartz

1 reference

4 August 2017

publication date

1 July 2002

1 reference

Trends in Molecular Medicine

4 August 2017

published in

1 reference

4 August 2017

1 reference

4 August 2017

1 reference

4 August 2017

page(s)

319-323

1 reference

Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Diffuse prolonged depression of cerebral oxidative metabolism following concussive brain injury in the rat: a cytochrome oxidase histochemistry study

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Mitochondrial dysfunction in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Acute neuronal apoptosis in a rat model of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Genetics of rat neuroinflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Axon damage and repair in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Bromocriptine in rheumatic and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Intense immune suppression for systemic lupus--the role of hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Immunosuppressive applications of PHA and other plant mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Therapeutic inhibition of the complement system. Y2K update

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Coadministration of methylprednisolone with hypertonic saline solution improves overall neurological function and survival rates in a chronic model of spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Multiple sclerosis and central nervous system demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Autoimmune T cells as potential neuroprotective therapy for spinal cord injury

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Autoimmunity can benefit self-maintenance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Protective autoimmunity is a physiological response to CNS trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Differential regulation of trophic factor receptor mRNAs in spinal motoneurons after sciatic nerve transection and ventral root avulsion in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Copolymer 1: from basic research to clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Oral tolerance with copolymer 1 for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Degeneracy, as opposed to specificity, in immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

T suppressor hybridomas and interleukin-2-dependent lines induced by copolymer 1 or by spinal cord homogenate down-regulate experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Studies on the mechanism and specificity of the effect of the synthetic random copolymer GLAT on graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Treatment of multiple sclerosis with Copaxone (COP): Elispot assay detects COP-induced interleukin-4 and interferon-gamma response in blood cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Characterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Genetic models for CNS inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Glia-T cell dialogue.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Antigen and superantigen presentation in the human CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Regulatory T cells in the control of immune pathology.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Glatiramer acetate in the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Concept of autoimmunity following spinal cord injury: possible roles for T lymphocytes in the traumatized central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Multiple sclerosis as a by-product of the failure to sustain protective autoimmunity: a paradigm shift

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Mechanisms of action of glatiramer acetate in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Multiple sclerosis: comparison of copolymer-1- reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

The link between excitotoxic oligodendroglial death and demyelinating diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Neurodegenerative disorders: the role of peroxynitrite

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

Nitric oxide, mitochondria and neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902373-0

7 January 2021

10.1016/S1471-4914(02)02373-0

Identifiers

DOI

1 reference

4 August 2017

1 reference